US: ANTI - Antigenics Inc
Yield per half year: +8 800%
Dividend yield: 0.00%
Reporting Antigenics Inc
Share
IFRS
Annual
Quarterly
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | LTM | 5 year average | CAGR 5 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Цена акции ао | 0.00055 | 5.0E-5 | 0.0001 | 0.0077 | 0.0105 | 0.0001 | 7.8E-5 | 0.0001 | 0.0001 | 0.0001 | 0.0022 | -60.58 |
Efficiency
IFRS
Annual
| 2024 | 2025 | LTM | Industry average | 5 year average | CAGR 5 | |
|---|---|---|---|---|---|---|
| ROS, % | 0 | 0 | 0 | |||
| ROCE, % | 0 | 0 | ||||
| Ebit margin, % | 0 | 0 | ||||
| Рентаб EBITDA, % | 0 | 0 | ||||
| Operation Margin, % | 0 | 0 | 0 |
Coefficients
IFRS
Annual
Quarterly
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
